Ruhn G, Erikson U, Olsson A G
Department of Diagnostic Radiology, Akademiska Sjukhuset, University of Uppsala, Sweden.
J Intern Med. 1989 May;225(5):317-23. doi: 10.1111/j.1365-2796.1989.tb00088.x.
Sixty-two male subjects with primary hyperlipoproteinaemia of type IIA (n = 18), type IIB (n = 18) or type IV (n = 24) underwent femoral arteriography to investigate the degree of atherosclerosis. All except two were free from symptoms of peripheral arterial disease. The presence of atheroma was determined according to a standardized consensus procedure based on visual interpretation. Atherosclerosis were graded by means of a scoring system, whereby an overall atherosclerosis score (OAS) was calculated for each patient, based on four consecutive segments of the femoral artery. Thirteen type IIA (72%), 14 type IIB (78%) and 18 type IV (75%) patients had femoral atherosclerosis, and the mean OAS in the patients with hyperlipoproteinaemia of these types were 0.58, 0.75 and 0.49, respectively, all with a standard error of the mean about 0.05. The atherosclerosis score increased the more distal the arterial segment, being most prevalent in the lower inferior segment. The OAS was higher in patients of above median age, in those with systolic or diastolic blood pressure above the median and in smokers. Multiple stepwise regression analysis showed that low density lipoproteins cholesterol was highly significantly related to OAS among smokers. In conclusion, femoral atherosclerosis is a prevalent finding in asymptomatic subjects with hyperlipoproteinaemia and could serve as a basis for intervention studies.
62名患有IIA型(n = 18)、IIB型(n = 18)或IV型(n = 24)原发性高脂蛋白血症的男性受试者接受了股动脉造影,以研究动脉粥样硬化的程度。除两人外,其他人均无外周动脉疾病症状。根据基于视觉判读的标准化共识程序确定动脉粥样硬化斑块的存在情况。通过评分系统对动脉粥样硬化进行分级,据此基于股动脉的四个连续节段为每位患者计算总体动脉粥样硬化评分(OAS)。13名IIA型患者(72%)、14名IIB型患者(78%)和18名IV型患者(75%)存在股动脉粥样硬化,这些类型高脂蛋白血症患者的平均OAS分别为0.58、0.75和0.49,均值的标准误差均约为0.05。动脉节段越靠远端,动脉粥样硬化评分越高,在下段最为普遍。年龄高于中位数的患者、收缩压或舒张压高于中位数的患者以及吸烟者的OAS更高。多元逐步回归分析显示,在吸烟者中,低密度脂蛋白胆固醇与OAS高度显著相关。总之,股动脉粥样硬化在无症状的高脂蛋白血症受试者中很常见,可为干预研究提供依据。